Baillie Gifford & Co
AXNX

Baillie Gifford & Co’s Axonics, Inc. Common Stock AXNX Stock Holding History

Baillie Gifford & Co’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-198
Closed -$10.8K – 442
2023
Q1 		$10.8K Hold
198
– – ﹤0.01% 395
2022
Q4 		$12.4K Hold
198
– – ﹤0.01% 398
2022
Q3 		$14K Hold
198
– – ﹤0.01% 376
2022
Q2 		$11K Hold
198
– – ﹤0.01% 407
2022
Q1 		$12K Hold
198
– – ﹤0.01% 424
2021
Q4 		$11K Sell
198
-32
-14% -$1.96K ﹤0.01% 443
2021
Q3 		$15K Hold
230
– – ﹤0.01% 409
2021
Q2 		$15K Hold
230
– – ﹤0.01% 388
2021
Q1 		$14K Sell
230
-19
-8% -$1.03K ﹤0.01% 375
2020
Q4 		$12K Buy
+249
New +$11.7K ﹤0.01% 372

Other funds holding AXNX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Baillie Gifford & Co's AXNX Position: Q2 2023 in Review

Baillie Gifford & Co sold out of Axonics, Inc. Common Stock (AXNX) in Q2 2023, closing a stake of 198 shares — an estimated $10.8K sold.

Baillie Gifford & Co first reported a position in AXNX in Q4 2020 and held it in 10 quarters. The position peaked at $15K in Q3 2021. 235 funds tracked by Wall St. Rank hold AXNX as of Q2 2023.

  • Baillie Gifford & Co reported no remaining Axonics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Baillie Gifford & Co sold 198 Axonics, Inc. Common Stock shares in Q2 2023, an estimated $10.8K.
  • Baillie Gifford & Co first reported a position in Axonics, Inc. Common Stock in Q4 2020 and held it in 10 quarters.
  • Baillie Gifford & Co's Axonics, Inc. Common Stock position peaked at $15K in Q3 2021.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q2 2023.

Based on Baillie Gifford & Co's 13F filing for Q2 2023, filed 28 Jul 2023.